Opus Genetics(formerly Ocuphire Pharma) — Post-IPO Equity
Opus Genetics(formerly Ocuphire Pharma) raised $25.0M in a Post-IPO Equity round. View investors, financials, and press on Fsome.
Round Details
- Funded Company
- Opus Genetics(formerly Ocuphire Pharma)
- Round Type
- Post-IPO Equity
- Amount Raised
- $25.0M
- Announced
- February 13, 2026
Canonical: https://fsome.com/funding/opus-genetics-formerly-ocuphire-pharma-post-ipo-equity-12379527 · For the full investor list, press references, and related rounds, please enable JavaScript.